Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

NCT05076175 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

NCT06311123 ·Status: RECRUITING

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

NCT05470985 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients

NCT01959165 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

NCT03464097 ·Status: TERMINATED ·Phase: PHASE3

An Early Phase 2 Clinical Study of KSP-0243

NCT05831670 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease

NCT00573469 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

NCT05907330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis

NCT07243639 ·Status: RECRUITING ·Phase: NA

Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis

NCT02818543 ·Status: COMPLETED ·Phase: PHASE1

Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis

NCT05341401 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice

NCT04963725 ·Status: COMPLETED

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385 ·Status: COMPLETED ·Phase: PHASE3

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440372 ·Status: TERMINATED ·Phase: PHASE3

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

NCT04882007 ·Status: COMPLETED ·Phase: PHASE2

Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success

NCT05702879 ·Status: RECRUITING

Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

NCT01612039 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring

NCT05953402 ·Status: NOT_YET_RECRUITING

Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study

NCT06188637 ·Status: WITHDRAWN ·Phase: PHASE4

A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants

NCT06126835 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

NCT04877990 ·Status: COMPLETED ·Phase: PHASE2

A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00853099 ·Status: COMPLETED ·Phase: PHASE3

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

NCT04583358 ·Status: UNKNOWN ·Phase: PHASE2

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

NCT04706793 ·Status: COMPLETED ·Phase: PHASE3

Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis

NCT04353791 ·Status: COMPLETED ·Phase: PHASE1/PHASE2